BAY 2416964 : Synchronized determination of sacubitril and valsartan with some co-administered drugs in human plasma via UPLC-MS/MS method using solid-phase extraction

Vanzacaftor : The future of CFTR modulating therapies for cystic fibrosis

Ki16198 : G protein-coupled receptors as promising cancer targets

Tipifarnib : Complete Remission Following Clofarabine Treatment in Refractory Juvenile Myelomonocytic Leukemia

STAT5-IN-1 : Ruxolitinib, an oral JAK1 and JAK2 inhibitor, in myelofibrosis